Pure Global
NCT06242561

Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study

Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study: a Preliminary Retrospective Study
Centre Hospitalier Régional Metz-Thionville·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Sepsis
Drug/Device/Intervention
Data collection from sepsis management
Study type
Observational
Intervention type
behavioral
Sponsor & location
Primary sponsor
Centre Hospitalier Régional Metz-Thionville
Location
Metz, France
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2024
End date
Mar 01, 2024
Enrollment
200 participants
Primary outcome

Total volume of fluids administered during the first 48 hours of ICU stay

Summary

This is a single-center retrospective study conducted at Mercy hospital, aiming to
 investigate the correlation between changes in hemoglobin (Hb) levels and the volume of
 vascular refill administered during the first 48 hours.

ICD-10 classifications
Other sepsisSepsis, unspecifiedOther specified sepsisCandidal sepsisPuerperal sepsis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06242561
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06242561 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Régional Metz-Thionville and is currently Recruiting. The study focuses on Sepsis. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.